Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06405945
Status:
RECRUITING
Last Update Posted:
2024-05-09
First Post:
2024-05-05
Brief Title:
Cervical Cancer Susceptible Population Classification
Sponsor:
Anhui Provincial Hospital
Organization:
Anhui Provincial Hospital
Study Overview
Official Title:
Evalutaion of the SNPs Test in Average Cervical Cancer Screening Episode
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Cervical cancer is the third most common lethal tumor globally causing around a quarter million deaths annually despite the availability of HPV vaccines Recent Genome-wide association studies GWAS have identified numerous genetic markers linked to cervical cancer including rs10175462 rs10007915 rs35721900 and rs61646675 which have been verified as being related to susceptibility to cervical cancer However many reports lack clarity consistency and validation In this comprehensive study we will analyze the genomic risk factors associated with cervical cancer classify individuals into different risk categories and explore potential biomarkers and therapeutics
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None